"Evasion of cell death" is a hallmark of cancer, enabling transformed cells to withstand oncogenic and therapeutic stress. Restoring cancer cell death is an appealing strategy but requires a deep understanding of cell death programs. Over the past two decades, the cell death field has expanded from apoptosis to include necroptosis, pyroptosis, ferroptosis, and other emerging programs, reshaping cancer biology and revealing therapeutic opportunities. While apoptosis remains the primary radiation- and chemotherapy-induced cell death program, non-apoptotic programs can drive inflammatory responses and orchestrate the interplay among tumor, stroma, and immune components, influencing immunotherapy outcomes. Ferroptosis, an iron-dependent, lipid peroxidation-driven cell death modality, lacks a canonical induction signal and arises from perturbations in lipid, iron, and redox metabolism. This review presents a unified framework for understanding the roles of major cell death programs in cancer development, progression, and treatment response, as well as addressing resistance to cancer cell death and immune suppression. "Our bodies are made of cells that live, and just as surely, of cells that must die." -S. Brenner.
FörderungenInteruniversity BOF projects National Natural Science Foundation of China Cancer Council Victoria Grant in Aid National Health and Medical Research Council (NHMRC) European Research Council (ERC) under the European Union BMBF program FERROPATH German Federal Ministry of Education and Research (BMBF) VIP+ program NEUROPROTEKT DFG CRC TRR 353 Priority Program SPP 2306 Foundation against Cancer Walter Benjamin Fellowship by the DFG
UGent Special Research Fund Methusalem Excellence of Science Research Consortium Research Foundation-Flanders FWF RU5659 TARGET-MPN FWF EU Tencent New Cornerstone Investigator Program Basic Science Center Project of the National Natural Science Foundation of China (NSFC) Deutsche Forschungsgemeinschaft (DFG)